Showing posts with label statins. Show all posts
Showing posts with label statins. Show all posts

Sunday, November 25, 2012

General Health Checkups and Medical Screening Tests—Do You Really Need Them?

By Dr. Mercola
Alan Cassels, a drug policy researcher at the University of Victoria in British Columbia, has written several books about the drug industry. His latest work is called Seeking Sickness: Medical Screening and the Misguided Hunt for Disease.
This book is loaded with helpful information about medical screening, and really focuses on an important topic, which is prevention.
It's been a longstanding passion of mine to prevent disease rather than to treat it, because it's so much easier to implement a preventive strategy. There is an enormous amount of effort and research invested in the traditional community into medical screening procedures.
The trouble is, conventional medicine views these medical tests as "prevention," when in fact there's nothing preventive about them at all. They're just diagnostic tools, and some aren't even all that accurate at that. Worse yet, some may be risky, and do more harm than good.
"I've been following the marketing tactics of the pharmaceutical industry for almost 18 years now," Cassels says. 
"I came upon screening partly because I started to see that a lot of people who ended up being put on certain regimes ended up there because they'd been through some screening regime – perhaps a screen for their blood cholesterol, a screen for their eyeball pressure, or even something simply as benign as screening for high blood pressure.
I started to look upstream from the pharmaceutical industry and really look at the kind of tactics that were used to entrap more and more people into drug regimes. And screening... is very pervasive."

To Screen, or Not to Screen?

A recent article in The Atlantic1, written by Oklahoma physician John Henning Schumann, MD, brings up the issue of over-screening—medical tests that simply are not necessary, or worse, detrimental. He discusses the case of one of his patients, who brought in results obtained from a "medical screening fair" at her local church.
The test was advertised as a bargain at $129, but according to Dr. Schumann, it was a complete waste of money considering she didn't have any risk factors warranting the testing. Besides relieving her of some hard-earned money, all it did was make her anxious when she really didn't need to be.
"I love America and the free market. I love companies that make a buck with hard work and ingenuity..." he writes. "But I don't love when innocent people get fleeced in the name of bad medicine that pretends to be good. Worse yet, when it happens at church. Commercial screening companies fiendishly target churches to find parishioners looking for healthy bargains. If your local church is endorsing a "health screening fair," it must be good, right?"
Yes, churches, synagogues and other houses of worship have recently been targeted by the medical industry in an effort to increase business. This became woefully apparent last year, when the White House Office of Faith-Based and Neighborhood Partnerships, co-sponsored by the U.S. Health and Human Services, the Office of Minority Health, and the CDC, held an invitation-only, off the record call2.
The focus of the call was on getting faith-based organizations to sponsor flu clinics with Walgreens. As an example, they cited a priest who stopped in the middle of mass to roll up his sleeve and get vaccinated, inspiring the rest of his parish to line up behind him. This has nothing to do with promoting good health. It's just another marketing shtick, and a potentially dangerous one at that. I'm sure the priest in question didn't stop to recount the many potential side effects before his flock took to the line to follow his lead.
"She didn't need these screening tests, and I'll tell you why," Dr. Schumann continues.
"As a non-smoking daily walker, her chance of having peripheral arterial disease (blockage of the leg arteries) is vanishingly small. The ultrasound of her abdomen, to search for an aneurysm of the aorta, is also a waste of money since her likelihood of having the condition borders on the absurd. The same is true for the ultrasound she received of her carotid arteries. In fact, the country's most influential (and controversial) authority on screening, the U.S. Preventive Services Task Force, recommends against all of the tests Mildred underwent as routine screening tests.
The broader issue on why excessive screening is bad is that it can lead to a cascade of obligatory follow-up costs down the line... Companies should not play on our fears to sell us unnecessary screening exams. When they do, we should be confident that we're better off not buying them."

Routine Health Checks Found to Have No Benefit

In related news, a recent study by the Cochrane Library3, the gold standard for independent medical reviews, found that:
"General health checks did not reduce morbidity or mortality, neither overall nor for cardiovascular or cancer causes, although the number of new diagnoses was increased. Important harmful outcomes, such as the number of follow-up diagnostic procedures or short term psychological effects, were often not studied or reported and many trials had methodological problems. With the large number of participants and deaths included, the long follow-up periods used, and considering that cardiovascular and cancer mortality were not reduced, general health checks are unlikely to be beneficial."
This may sound shocking to many, as general health checks are typically considered to be part and parcel of early disease detection and prevention. However, after reviewing the health outcomes of nearly 183,000 people, the researchers found that, in terms of making you live longer, getting regular health check-ups doesn't appear to make a difference...
Regular screening may however increase your drug use, and you may receive a diagnosis and treatment for a condition that might never have led to any symptoms or had any impact on your longevity. According to lead researcher Lasse Krogsbøll4 of The Nordic Cochrane Centre in Copenhagen, Denmark:
"What we're not saying is that doctors should stop carrying out tests or offering treatment when they suspect there may be a problem. But we do think that public healthcare initiatives that are systematically offering general health checks should be resisted."
This isn't the first time researchers have concluded we may be over-testing and over-treating. In fact, over the past few years this has become increasingly studied, and most analyses concur that more testing and more aggressive treatment does not translate into reduced mortality. Naturally, there's no way to make recommendations here that could apply to everyone or even most people. Evaluating your risk factors is one important factor of course, as stated in Dr. Schumann's article. Evaluating your symptoms is another. If you're asymptomatic, maintain a healthy, active lifestyle, and don't have any risk factors, perhaps signing up for a bunch of medical tests at your local church, "just in case," is not in your best interest.

Medical Screenings—Heavily Promoted to Increase Sales of Post-Screening Activity

Alan Cassels also has something to say about this:
"[S]o much of what we consider to be disease in the orthodox medicine world has been created, has been shaped, and has really been molded by the pharmaceutical industry," he says. "And very much what we consider to be medicine is determined by the kinds of things that end in what the drug industry calls the 'drug successful visit.' Not just anything that we potentially could be sick with, but anything that any healthy person could get.
And really, screening is about looking in healthy people to find signs of disease.
I want to distinguish right off the bat that when I'm talking about screening, I'm talking about people who have no symptoms, who are otherwise healthy, and who have really no reason to consult the doctor or being told, 'You need to be proactive. You need to seek out early signs of disease. That's a good thing to do to keep yourself healthy.' People that actually have symptoms – feel a lump or whatever – and then go in for a test, that's a diagnostic test. That's something different.
I'm talking about a screening test where you're taking otherwise healthy people and trying to find signs of disease in them."

Common Cancer Screens Can Do More Harm than Good

Much like myself, Cassels research has led him to seriously question common tests like mammography for breast cancer, and the PSA test for prostate cancer. In the interview above he explains:
"[O]ne thing that we know for sure is that a lot of the activity around screening makes a lot of money for a lot of people. One example might be the whole world of mammography... [W]e're telling healthy women who have no symptoms, 'Go in every year. From the day you turn 40, go in once a year, and have your breasts radiologically screened.'
What we're not telling women is that just the act of screening involves a whole downstream potential for harm and also involves huge amounts of certain medical resources in terms of the radiologist, the surgeons, and so on.
It's a huge industry. You might say, 'Well, what's wrong with that industry if it's actually saving lives?' Well, when you sit down, and you look at the number of women that have to be screened in order to have one woman benefit, it's actually quite shocking... The best studies (these are studies that are over 10-years long and done in Canada, the U.S., and in Europe), have found that you have to screen 2,100 women every year for 11 years to prevent one death. So, to answer the question, 'Is it lifesaving?' Yes. One in 2,100 women would benefit from being screened over an 11-year period.
But at the same time, of those 2,100 women, about 600 to 700 of them will have a false-positive. They will find something unusual or something abnormal, and that will require biopsies, open surgeries, mastectomies, and so on. Not to mention the psychological harm of inflicting a cancer scare... The problem is that you're generating a huge amount of activity to save one in 2,000 women. In the best-case scenario, you're causing 600 or 700 women to have huge amounts of procedure... It seems to me that it's an awfully high cost to pay to prevent one death.
And I think that there are many, many other things that we can do to try to reduce the risk of breast cancer in women rather than telling them to get their annual mammography screen."
The male version of mammography is the annual PSA test. It's a simple blood test that measures the level of an antigen in your blood. An elevated reading could indicate that you have prostate cancer, or are at increased risk of developing prostate cancer. Or not, as the PSA test is notoriously inaccurate...
"What most men aren't being told – this is from the research that I did – is when they're given that test, the likelihood of them finding cancer cells in their prostate are fairly high," Cassels explains.
"In fact, it's directly proportional to your age. If you live to be 60 or 70 years old, there's a good chance you're going to have a 60 percent chance of having some evidence of prostate cancer. You might say, 'Wow, if you've got prostate cancer, shouldn't you do something about it?'
Well, certainly with the PSA test and its lack of specificity and accuracy, you've got 60 or 70 percent of the male population that will develop prostate cancer in their lifetime. But only about three percent of men will die from prostate cancer.
What doctors have told me is that most men will die with prostate cancer, but not because of it. And that's really kind of a mindblowing concept for a lot of people, because they think what you're saying is that, 'I can have a cancer in my body and live a perfectly, long, and healthy life.' Absolutely.
One of the things that screening is good at is finding signs of disease. What it's not very good at is finding disease that matters. In this case, having an elevated PSA level could be caused by a whole range of things. And if you're otherwise asymptomatic, going down that line of getting tested will lead to biopsies, possibly surgery, other kinds of treatment including chemotherapy, and hormone therapy. At the end of the day, a lot of the men that go through that mill end up becoming incontinent or impotent because of the treatment."

Medical Science Rarely a Slam Dunk

In related news, a recent study5 by Dr. John Ioannidis of the Stanford School of Medicine in California warns against placing too much faith in medical studies showing very large effects of medical treatment (benefits or harms). The massive analysis tracked the fate of thousands of studies, from the effects demonstrated in the initial study, compared to the effects elucidated in subsequent trials.
Interestingly, in 90 percent of cases where "very large" effects were initially reported, such effects shrank or vanished altogether as subsequent studies were done to confirm the results. Dr. Ioannidis told Reuters6:
"Our analysis suggests it is better to wait to see if these very large effects get replicated or not... Keep some healthy skepticism about claims for silver bullets, perfect cures, and huge effects."
Typically, studies reporting very significant effects are based on smaller, less reliable experiments. This is because small trials are more likely to be skewed by chance alone. The authors also point out that studies showing very large effects rarely address mortality, and are more likely to address laboratory-defined efficacy. Alas, changes in lab values does not necessarily equate to improved health... Sometimes, this kind of efficacy could actually be disastrous.
Dr. Andrew Oxman of the Norwegian Knowledge Centre for the Health Services in Oslo, who wrote an editorial7 about the study, told Reuters8:
"'There are lots of examples where things start to be used and have entered the market based on surrogate outcomes and then actually proved harmful.' He mentioned the heart rhythm drugs encainide and flecainide, which for many years were given to people with acute heart attacks. But then trials showed they were actually bad for these patients. 'These drugs were by given well-meaning clinicians, but they actually killed more people than the Vietnam War did,' Oxman said.
Statins are another perfect example of this, as they are very effective at reducing your cholesterol level, yet wreak all sorts of havoc in your body while doing so. If you're not careful it may even lead to premature death. Your cholesterol numbers will probably be a-okay though, if that brings any relief to anyone, and your death will be chalked up to some other health problem.
According to Cassels:
"[W]hen you look at the big meta-analyses of statin drugs, there are about five major studies that have tens of thousands of patients in them... testing drugs like simvastatin or atorvastatin (Zocor or Lipitor). When you look at the totality of those studies, the one thing that you find is that the benefit, in terms of reduction in heart attack or stroke for people who haven't had a heart attack or stroke (we're talking primary prevention), is simply not there.
You can alter cholesterol quite easily using cholesterol-lowering drugs. But the question is, 'What's important? Having your cholesterol altered or reducing your risk and reducing the chance that you could have a heart attack?'
I think that the main thing that has happened... [is that] we focus on the numbers... when in fact, what really counts is whether you have a heart attack or stroke.
Of course, it takes long-term studies, five- and 10-year long studies, to determine whether drugs will prevent that. And certainly in the primary prevention population, you don't see any reductions. Women don't benefit from having their cholesterol altered with statins, and certainly [not] the elderly. Some of the newer research is showing that older people who have higher cholesterol actually have a protective effect from that."

Final Thoughts

Of the tens of thousands of treatments evaluated in Dr. Ioannidis study, only one stood out as a clear "slam dunk" in terms of the benefit of treatment. A respiratory intervention in newborns repeatedly demonstrated a reliable, very large drop in death rates. That really tells us something about "evidence-based medicine," doesn't it?
It's not at all as clear-cut as conventional doctors and health authorities would like us to believe. Today, I think many treatment recommendations, especially in terms of drugs and vaccines, are clearly premature and based on very flimsy evidence. The same applies to many of the medical screening tests available. The evidence of real benefit simply isn't there in many cases.
"I guess the summary statement is: go into the screening with your eyes wide open," Cassels says.
"And that is to say that it's not an emergency procedure. If you're being offered a screen of any sort whether it's a mental health screen, a screening of osteoporosis, for blood pressure, cholesterol, or for cancers, take the time to ask the questions. 'How could I be hurt by this screening?'
When you actually understand that a screening can potentially harm you, you might take a very different approach to rushing into it. You might take more time to actually do some research. And really when you do research, it's important that you look at independent sources of information.
... The United States Preventive Services Task Force—their stuff is all available on the Internet. In terms of the spectrum of trustworthiness, I would place that in the More Trustworthy category, as opposed to the other category, which might be those groups that stand to benefit from screening and over-promote and overpromise on screening's benefits. So, really, independent information is I think key, and knowing that screening can potentially harm you."

 http://www.youtube.com/watch?v=-oczZye3hpY

  Internet Marketing Business Opportunities

Thursday, June 7, 2012

Newest Scam to Increase Drugs If You’re Older than 50

 

Story at-a-glance

  • The odds are very high – likely greater than 1000 to 1 -- that if you're taking a statin, you may not even need it, and this is true regardless of age; there are better options for lowering your heart attack risk
  • In the U.S., health regulators recently ruled that warning labels be added to statins because they can cause muscle weakness, diabetes, memory loss and depression
  • The study was littered with conflicts of interest, as most of the trials were funded by the pharmaceutical industry, and some of the researchers even received money and recognition from drug companies
  • In a related commentary, it’s stated that everyone aged 50 and over should take statin cholesterol-lowering drugs
  • A new study suggested that the benefits of statins outweigh the risks of side effects, even for healthy people with a low risk of heart attacks and stroke.    
    By Dr. Mercola
    A UK Daily Mail headline from May 2012 read: "Why EVERYONE over 50 needs to be taking statins."i If you find the notion that taking medications should be construed as something for everyone, like drinking water or breathing air, as appalling as I do, then you will probably be equally taken aback by this lofty statement.
    But to blame the Daily Mail wouldn't be entirely fair, as they are merely reporting the results of a new study published in the Lancet.
    Media around the world picked up these findings, but reporters apparently missed the conflict-of-interest disclaimers at the end … which should make any logical person think twice before agreeing with them.

    Statins for Everyone Once You Reach Your 50th Birthday?

    Millions of people around the world take medications known as statins to lower their cholesterol. Typically, they are reserved for people considered to be at high risk of heart attack or stroke, usually (incorrectly) defined as someone with "high" cholesterol. The current value of the cholesterol-lowering drug industry is estimated at around $29 billion a year – but the pharmaceutical industry is still salivating at the thought of how big that number could get if statins could be prescribed to even more people.
    Well, they must have popped open their most expensive champagne when researchers came to this very conclusion in a recent issue of the Lancet...
    After reviewing findings from 27 trials that included people who were at low risk of heart problems, the researchers concluded that the benefits of statins outweigh the risks, to the extent that they may even benefit healthy people without high cholesterol and with little risk of heart attack or stroke. Currently in the UK, the drugs are only recommended for those with at least a 20 percent risk of heart attack or stroke in the next decade, but the researchers suggested the National Health Service (NHS) guidelines should be revised to include their use even in those without an increased risk.
    In a commentary also published in the Lancet, it's written that the most ""cost-effective" way to start prescribing statins to the masses is simply to give them to everyone once they reach age 50:ii
    "Because most people older than 50 years are likely to be at greater than 10% 10-year risk of cardiovascular disease, it would be more pragmatic to use age as the only indicator for statin prescription, as was originally proposed for the polypill."
    It is this statement that has transmogrified into the sensational media headlines that make it sound as though statins for over-50s should be the new status quo … but then, where is the mention of who funded all of this favorable statin research? It also makes one seriously consider the influences on the researchers that conducted this study. With so much money at stake it is very hard to believe that the drug industry did not have something to produce or manipulate the recommendations.

    Didn't Anyone Read the Conflicts of Interest Disclaimer?

    It's right there in black and white, at the end of the Lancet study -- the stated conflicts of interest:
    "Most of the trials in this report were supported by research grants from the pharmaceutical industry. Some members of the writing committee have received reimbursement of costs to participate in scientific meetings from the pharmaceutical industry. AK and JS have also received honoraria from Solvay for lectures related to these studies."
    This changes everything, as it's well known that pharma-funded studies are often manipulated to show positive results even when the opposite holds true. And researchers who are connected monetarily to the companies producing the products being studied are only all too happy – even if it's subconsciously -- to "massage" the data accordingly.
    In the video below, Dr. Beatrice Golomb, MD, PhD -- an associate professor of medicine and associate professor of family and preventive medicine at the University of California at San Diego -- shares shocking information about the dark underbelly of medical science to help you understand how, and why, the "scientific method" has become so manipulated and willfully distorted by the drug industry.
    For starters, in order for scientific studies to happen, someone has to pay for them. The top funder for any drug trial is the pharmaceutical company that makes it, since the manufacturer is most invested in "proving" how spectacular its drug is.
    Dr. Golomb uses the case of statins as an example, stating that all of the major statin studies have been funded exclusively by the drug industry. Further, drug companies publish only a fraction of the studies they fund -- the ones that promote the "safe and effective" image of their drugs. Often those favorable studies are submitted multiple times, in a way that the reader doesn't realize it's the same study, obscured by different author lists and different details. If a study does not have findings that are favorable to its product, it is unlikely it will ever make it into a journal for publication.
    But, when a scientific study has findings that cast doubt on the efficacy of a drug, oftentimes the negative findings are morphed into positive ones through statistical and semantic manipulation.       Click link to read interview transcript :-
     http://mercola.fileburst.com/PDF/ExpertInterviewTranscripts/InterviewBeatricGolombApr302010.pdf
    When it comes to medicine, mere disclosure of conflict of interest is not nearly enough. Patients need unbiased advice when it comes to making decisions that can impact their very life, and physicians and scientists with financial ties to the drug industry should not be allowed to participate in research … let alone research that might be used to make broad policy and public-health recommendations …

    FDA Demands Warning Labels on Statins

    It's ironic that this new research comes in the wake of U.S. health regulators' orders to put warning labels on statins because they can cause muscle weakness, diabetes, memory loss and depression. The Lancet researchers felt it was more important to avoid heart attacks and strokes than to worry about possible side effects … but statins appear to provoke serious risks of chronic disease, including diabetes, through a few different mechanisms. One primary mechanism is by increasing your insulin levels, which can be extremely harmful to your health.
    Chronically elevated insulin levels cause inflammation in your body, which is the hallmark of most chronic disease. In fact, elevated insulin levels lead to heart disease, which, ironically, is the primary reason for taking a statin drug in the first place! It can also promote belly fat, high blood pressure, heart attacks, chronic fatigue, thyroid disruption, and diseases like Parkinson's, Alzheimer's, and cancer.
    Statins also increase your diabetes risk by raising your blood sugar. When you eat a meal that contains starches and sugar, some of the excess sugar goes to your liver, which then stores it away as cholesterol and triglycerides.
    Statins work by preventing your liver from making cholesterol. As a result, your liver returns the sugar to your bloodstream, which raises your blood sugar levels.
    These drugs also rob your body of certain valuable nutrients, which can also impact your blood sugar levels. Two nutrients in particular, vitamin D and CoQ10, are both needed to maintain ideal blood glucose levels. The loss of CoQ10 leads to loss of cell energy and increased free radicals which, in turn, can further damage your mitochondrial DNA, effectively setting into motion a health-destroying circle of increasing free radicals and mitochondrial damage.
    There are no official warnings in the United States regarding CoQ10 depletion from taking statin drugs, and many physicians fail to inform you about this problem as well. Labeling in Canada, however, clearly warns of CoQ10 depletion and even notes that this nutrient deficiency "could lead to impaired cardiac function in patients with borderline congestive heart failure."
    As your body gets more and more depleted of CoQ10, you may suffer from fatigue, muscle weakness and soreness, and eventually heart failure, so it is imperative if you take statin drugs that you take CoQ10 or, if you are over the age of 40, or subject to excessive oxidative stress, the reduced version called ubiquinol. This is only a short list, as statin drugs have been directly linked to over 300 side effects,iii which include:
    thy Anemia
    AcidosisFrequent fevers Cataracts
    S
    Cognitive loss
    exual dysfunction
    An increase in cancer risk Pancreatic dysfunction
    Immune system suppression Muscle problems, polyneuropathy (nerve damage in the hands and feet), and rhabdomyolysis, a serious degenerative muscle tissue condition Hepatic dysfunction. (Due to the potential increase in liver enzymes, patients must be monitored for normal liver function)

    Anemia
    Cataracts
     Pancreatic dysfunction
     Hepatic dysfunction. (Due to the potential increase in liver enzymes, patients must be monitored for normal liver function)
    Acidos
    Frequent feversCataracts
    is

    Cognitive loss Neuropathy Anemia



    Sexual dysfunction An increase in cancer risk Pancreatic dysfunction
    Immune system suppression Muscle problems, polyneuropathy (nerve damage in the hands and feet), and rhabdomyolysis, a serious degenerative muscle tissue condition Hepatic dysfunction. (Due to the potential increase in liver enzymes, patients must be monitored for normal liver function)

    Most People Don't Need Statins, Regardless of Age

    I've long stated that the odds are very high -- greater than 100 to 1 -- that if you're taking a statin, you may not even need it. To understand why you probably don't need a statin drug, you first need to realize that cholesterol is NOT the cause of heart disease. If your physician is urging you to check your total cholesterol, know that this test will tell you virtually nothing about your risk of heart disease, unless it is 330 or higher. HDL percentage is a far more potent indicator for heart disease risk. Here are the two ratios you should pay attention to:
    1. HDL/Total Cholesterol Ratio: Should ideally be above 24 percent. If below 10 percent, you have a significantly elevated risk for heart disease.
    2. Triglyceride/HDL Ratio: Should be below 2.
    Moreover, the waist-to-hip ratio, apolipoprotein a/b ratio, fibrinogen and an increasingly complex number of factors have been identified that, collectively, have far more relevance in determining your cardiovascular disease and/or cardiac mortality risk than any as yet to be identified lipid or lipoprotein in your blood. Is our lipid-obsession, then, really justified, or is it an integral part of a $29-billion statin drug industry that requires myopia and a general dumbing down of the medical community in order to perpetuate itself?
    The truth is, statins are some of the most side-effect-ridden medications on the market, and they frequently cause more harm than good. If you are interested in optimizing your cholesterol levels (which doesn't necessarily mean lowering them), and in lowering your risk of heart attack and stroke naturally, there are many strategies available for doing so.
    • Reduce, with the plan of eliminating, grains and sugars (including fructose) in your diet, replacing them with mostly whole, fresh vegetable carbs. Also try to consume a good portion of your food raw.
    • Make sure you are getting enough high quality, animal-based omega 3 fats, such as krill oil.
    • Other heart-healthy foods include olive oil, coconut and coconut oil, organic raw dairy products and eggs, avocados, raw nuts and seeds, and organic grass-fed meats as explained in my nutrition plan
    • Optimize your vitamin D levels using safe sun exposure, a safe tanning bed or a vitamin D3 supplement
    • Exercise regularly, especially with Peak Fitness exercises.
    • Avoid smoking or drinking alcohol excessively.
    • Be sure to get plenty of good, restorative sleep.
    References:

  • i UK Mail Online May 16, 2012
  • ii The Lancet, Early Online Publication, May 17, 2012
  • iii GreenMedInfo.com Statin Drugs